View Page
Export to Word
Export to PDF
Archive
Page history
A
t
tachments (0)
Page Information
View Source
Convert Gliffy Diagrams
Content
…
FAQs
FAQ articles
About the CanRisk Tool
How are rare genetic pathogenic variants in BRCA1, BRCA2, PALB2, ATM, CHEK2 , RAD51C, RAD51D, and BRIP1 used in the CanRisk Tool?
Page Comparison
Versions Compared
Old Version
3
changes.mady.by.user
Tim Carver
Saved on
May 27, 2021
compared with
New Version
4
changes.mady.by.user
Tim Carver
Saved on
May 27, 2021
Previous Change: Difference between versions 2 and 3
Next Change: Difference between versions 4 and 5
View Page History
Key
This line was added.
This line was removed.
Formatting was changed.
The CanRisk Tool only considers the effects of truncating variants in ATM
and CHEK2
. Please see the explanation for this in the Discussion section of the
Genet. Med. 18, 1190–1198 (2016)
.
Manage space
Manage content
Integrations
App links
{"serverDuration": 182, "requestCorrelationId": "eb423301b79544038c8230b35703e78c"}